Targeting RING domains of Mdm2–MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells

Reactivation of tumor-suppressor p53 for targeted cancer therapy is an attractive strategy for cancers bearing wild-type (WT) p53. Targeting the Mdm2–p53 interface or MdmX ((MDM4), mouse double minute 4)–p53 interface or both has been a focus in the field. However, targeting the E3 ligase activity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, W, Xu, C, Ling, X, Fan, C, Buckley, B P, Chernov, M V, Ellis, L, Li, F, Muñoz, I G, Wang, X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720891/
https://www.ncbi.nlm.nih.gov/pubmed/26720344
http://dx.doi.org/10.1038/cddis.2015.358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720891/
https://www.ncbi.nlm.nih.gov/pubmed/26720344
http://dx.doi.org/10.1038/cddis.2015.358

Ejemplares similares